Profile data is unavailable for this security.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zentek Ltd | 35.31k | -11.10m | 89.70m | 25.00 | -- | 4.74 | -- | 2,540.34 | -0.1103 | -0.1103 | 0.0004 | 0.1813 | 0.0014 | 0.1621 | 0.1309 | 1,412.40 | -42.89 | -47.65 | -46.51 | -51.12 | -909.46 | -- | -31,439.08 | -13,980.33 | 1.54 | -- | 0.0558 | -- | -59.07 | -- | 18.80 | -- | -19.38 | -- |
Eupraxia Pharmaceuticals Inc | 0.00 | -36.92m | 113.89m | 29.00 | -- | 5.61 | -- | -- | -1.37 | -1.37 | 0.00 | 0.5682 | 0.00 | -- | -- | 0.00 | -137.69 | -127.84 | -270.60 | -935.99 | -- | -- | -- | -- | -- | -- | 0.2545 | -- | -- | -- | -52.63 | -- | -7.69 | -- |
Oncolytics Biotech Inc | 0.00 | -28.02m | 133.28m | 29.00 | -- | 7.26 | -- | -- | -0.3827 | -0.3827 | 0.00 | 0.2383 | 0.00 | -- | -- | -- | -87.53 | -81.99 | -101.45 | -97.25 | -- | -- | -- | -- | -- | -- | 0.0575 | -- | -- | -- | -11.75 | -- | -40.52 | -- |
NervGen Pharma Corp | 0.00 | -23.08m | 169.15m | 10.00 | -- | 13.52 | -- | -- | -0.3678 | -0.3678 | 0.00 | 0.1783 | 0.00 | -- | -- | -- | -101.90 | -121.15 | -227.88 | -180.20 | -- | -- | -- | -- | -- | -5.04 | 0.012 | -- | -- | -- | -8.01 | -- | 2.20 | -- |
Medicenna Therapeutics Corp | 0.00 | -26.24m | 172.37m | 16.00 | -- | 7.52 | -- | -- | -0.374 | -0.374 | 0.00 | 0.2994 | 0.00 | -- | -- | 0.00 | -75.44 | -54.93 | -84.22 | -60.91 | -- | -- | -- | -- | -- | -2.29 | 0.00 | -- | -- | -- | -153.44 | -- | -- | -- |
Cardiol Therapeutics Inc | 0.00 | -29.34m | 188.41m | 17.00 | -- | 12.14 | -- | -- | -0.4415 | -0.4415 | 0.00 | 0.2216 | 0.00 | -- | -- | -- | -79.85 | -58.97 | -108.15 | -68.62 | -- | -- | -- | -158,738.10 | -- | -- | 0.0106 | -- | -- | -- | 9.06 | -- | 36.06 | -- |
Data as of Oct 09 2024. Currency figures normalised to Medicenna Therapeutics Corp's reporting currency: Canadian Dollar CAD